Loading…

Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair

Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 2012-09, Vol.56 (3), p.630-636
Main Authors: Abularrage, Christopher J., MD, Patel, Virendra I., MD, Conrad, Mark F., MD, MMSc, Schneider, Eric B., PhD, Cambria, Richard P., MD, Kwolek, Christopher J., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903
cites cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903
container_end_page 636
container_issue 3
container_start_page 630
container_title Journal of vascular surgery
container_volume 56
creator Abularrage, Christopher J., MD
Patel, Virendra I., MD
Conrad, Mark F., MD, MMSc
Schneider, Eric B., PhD
Cambria, Richard P., MD
Kwolek, Christopher J., MD
description Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P < .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.
doi_str_mv 10.1016/j.jvs.2012.02.038
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1035107872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521412003874</els_id><sourcerecordid>1035107872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhoMo7rj6A7xILoKXHpN0upNGEGTxY2FhD-o5ZNKVNb39ZSo92P_etDMqeBAKQhXPW1V5KUKec7bnjNevu313xL1gXOxZjlI_IDvOGlXUmjUPyY4pyYtKcHlBniB2jHFeafWYXAhRKcFYsyN4PcxxOkJLI-DSJ6QLhvGO3o7rD3rXL0D9FGn6BjRFsGmAMdHJ0xkiBkxbltYZqKAwtlMP9p5anyD-So8W3dLbSO0IS1xxyDNmG-JT8sjbHuHZ-b0kXz-8_3L1qbi5_Xh99e6mcFLzVKiDBl2zA3dSwIHJStaVkl76srYeap1rnMmStdLVwLm23paVqGvvJFSsYeUleXXqm3_4fQFMZgjooO_zPtOChrOy4kxpJTLKT6iLE2IEb-YYBhvXDJnNa9OZ7LXZvDYsR6mz5sW5_XIYoP2j-G1uBl6egWyE7X20owv4l6tF0zSKZ-7NiYNsxjFANOgCjA7aEMEl007hv2u8_Uft-jCGPPAeVsBuWuKYXTbcYBaYz9tRbDfB846lVrL8CfCDslg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035107872</pqid></control><display><type>article</type><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</creator><creatorcontrib>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</creatorcontrib><description>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P &lt; .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2012.02.038</identifier><identifier>PMID: 22572009</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Aged ; Aneurysm - mortality ; Aneurysm - surgery ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - mortality ; Boston ; Cardiology. Vascular system ; Chi-Square Distribution ; Dimethyl Sulfoxide - adverse effects ; Dimethyl Sulfoxide - therapeutic use ; Diseases of the aorta ; Drug Combinations ; Embolization, Therapeutic - adverse effects ; Embolization, Therapeutic - methods ; Embolization, Therapeutic - mortality ; Endoleak - diagnostic imaging ; Endoleak - etiology ; Endoleak - mortality ; Endoleak - therapy ; Endovascular Procedures - adverse effects ; Endovascular Procedures - mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Medical sciences ; Multivariate Analysis ; Odds Ratio ; Polyvinyls - adverse effects ; Polyvinyls - therapeutic use ; Proportional Hazards Models ; Reoperation ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tantalum - adverse effects ; Tantalum - therapeutic use ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><ispartof>Journal of vascular surgery, 2012-09, Vol.56 (3), p.630-636</ispartof><rights>Society for Vascular Surgery</rights><rights>2012 Society for Vascular Surgery</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</citedby><cites>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26299971$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22572009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abularrage, Christopher J., MD</creatorcontrib><creatorcontrib>Patel, Virendra I., MD</creatorcontrib><creatorcontrib>Conrad, Mark F., MD, MMSc</creatorcontrib><creatorcontrib>Schneider, Eric B., PhD</creatorcontrib><creatorcontrib>Cambria, Richard P., MD</creatorcontrib><creatorcontrib>Kwolek, Christopher J., MD</creatorcontrib><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P &lt; .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</description><subject>Aged</subject><subject>Aneurysm - mortality</subject><subject>Aneurysm - surgery</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - mortality</subject><subject>Boston</subject><subject>Cardiology. Vascular system</subject><subject>Chi-Square Distribution</subject><subject>Dimethyl Sulfoxide - adverse effects</subject><subject>Dimethyl Sulfoxide - therapeutic use</subject><subject>Diseases of the aorta</subject><subject>Drug Combinations</subject><subject>Embolization, Therapeutic - adverse effects</subject><subject>Embolization, Therapeutic - methods</subject><subject>Embolization, Therapeutic - mortality</subject><subject>Endoleak - diagnostic imaging</subject><subject>Endoleak - etiology</subject><subject>Endoleak - mortality</subject><subject>Endoleak - therapy</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multivariate Analysis</subject><subject>Odds Ratio</subject><subject>Polyvinyls - adverse effects</subject><subject>Polyvinyls - therapeutic use</subject><subject>Proportional Hazards Models</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tantalum - adverse effects</subject><subject>Tantalum - therapeutic use</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kk2LFDEQhoMo7rj6A7xILoKXHpN0upNGEGTxY2FhD-o5ZNKVNb39ZSo92P_etDMqeBAKQhXPW1V5KUKec7bnjNevu313xL1gXOxZjlI_IDvOGlXUmjUPyY4pyYtKcHlBniB2jHFeafWYXAhRKcFYsyN4PcxxOkJLI-DSJ6QLhvGO3o7rD3rXL0D9FGn6BjRFsGmAMdHJ0xkiBkxbltYZqKAwtlMP9p5anyD-So8W3dLbSO0IS1xxyDNmG-JT8sjbHuHZ-b0kXz-8_3L1qbi5_Xh99e6mcFLzVKiDBl2zA3dSwIHJStaVkl76srYeap1rnMmStdLVwLm23paVqGvvJFSsYeUleXXqm3_4fQFMZgjooO_zPtOChrOy4kxpJTLKT6iLE2IEb-YYBhvXDJnNa9OZ7LXZvDYsR6mz5sW5_XIYoP2j-G1uBl6egWyE7X20owv4l6tF0zSKZ-7NiYNsxjFANOgCjA7aEMEl007hv2u8_Uft-jCGPPAeVsBuWuKYXTbcYBaYz9tRbDfB846lVrL8CfCDslg</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Abularrage, Christopher J., MD</creator><creator>Patel, Virendra I., MD</creator><creator>Conrad, Mark F., MD, MMSc</creator><creator>Schneider, Eric B., PhD</creator><creator>Cambria, Richard P., MD</creator><creator>Kwolek, Christopher J., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><author>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aneurysm - mortality</topic><topic>Aneurysm - surgery</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - mortality</topic><topic>Boston</topic><topic>Cardiology. Vascular system</topic><topic>Chi-Square Distribution</topic><topic>Dimethyl Sulfoxide - adverse effects</topic><topic>Dimethyl Sulfoxide - therapeutic use</topic><topic>Diseases of the aorta</topic><topic>Drug Combinations</topic><topic>Embolization, Therapeutic - adverse effects</topic><topic>Embolization, Therapeutic - methods</topic><topic>Embolization, Therapeutic - mortality</topic><topic>Endoleak - diagnostic imaging</topic><topic>Endoleak - etiology</topic><topic>Endoleak - mortality</topic><topic>Endoleak - therapy</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multivariate Analysis</topic><topic>Odds Ratio</topic><topic>Polyvinyls - adverse effects</topic><topic>Polyvinyls - therapeutic use</topic><topic>Proportional Hazards Models</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tantalum - adverse effects</topic><topic>Tantalum - therapeutic use</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abularrage, Christopher J., MD</creatorcontrib><creatorcontrib>Patel, Virendra I., MD</creatorcontrib><creatorcontrib>Conrad, Mark F., MD, MMSc</creatorcontrib><creatorcontrib>Schneider, Eric B., PhD</creatorcontrib><creatorcontrib>Cambria, Richard P., MD</creatorcontrib><creatorcontrib>Kwolek, Christopher J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abularrage, Christopher J., MD</au><au>Patel, Virendra I., MD</au><au>Conrad, Mark F., MD, MMSc</au><au>Schneider, Eric B., PhD</au><au>Cambria, Richard P., MD</au><au>Kwolek, Christopher J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>56</volume><issue>3</issue><spage>630</spage><epage>636</epage><pages>630-636</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P &lt; .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>22572009</pmid><doi>10.1016/j.jvs.2012.02.038</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2012-09, Vol.56 (3), p.630-636
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_1035107872
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Aged
Aneurysm - mortality
Aneurysm - surgery
Biological and medical sciences
Blood and lymphatic vessels
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - mortality
Boston
Cardiology. Vascular system
Chi-Square Distribution
Dimethyl Sulfoxide - adverse effects
Dimethyl Sulfoxide - therapeutic use
Diseases of the aorta
Drug Combinations
Embolization, Therapeutic - adverse effects
Embolization, Therapeutic - methods
Embolization, Therapeutic - mortality
Endoleak - diagnostic imaging
Endoleak - etiology
Endoleak - mortality
Endoleak - therapy
Endovascular Procedures - adverse effects
Endovascular Procedures - mortality
Female
Humans
Kaplan-Meier Estimate
Logistic Models
Male
Medical sciences
Multivariate Analysis
Odds Ratio
Polyvinyls - adverse effects
Polyvinyls - therapeutic use
Proportional Hazards Models
Reoperation
Retrospective Studies
Risk Assessment
Risk Factors
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tantalum - adverse effects
Tantalum - therapeutic use
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels
title Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20results%20using%20Onyx%20glue%20for%20the%20treatment%20of%20persistent%20type%202%20endoleak%20after%20endovascular%20aneurysm%20repair&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Abularrage,%20Christopher%20J.,%20MD&rft.date=2012-09-01&rft.volume=56&rft.issue=3&rft.spage=630&rft.epage=636&rft.pages=630-636&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2012.02.038&rft_dat=%3Cproquest_cross%3E1035107872%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1035107872&rft_id=info:pmid/22572009&rfr_iscdi=true